Cannabinoid pharmacology in cancer research: A new hope for cancer patients?

European Journal of Pharmacology

Volumn 775, Issue , 2016, Pages 1-14

  Javid, Farideh A ^a   Phillips, Roger M ^a   Afshinjavid, S ^b   Verde, Roberta ^c   Ligresti, Alessia ^c  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^b UNIVERSITY OF CHESTER   (United Kingdom)

^c CNR   (Italy)

Author keywords

Cancer; Cannabinoid receptors; Cannabinoids

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 ARACHIDONOYLGLYCEROL; 2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABIDIOL; CANNABINOID; CAPSAICIN; DEXANABINOL; DRONABINOL; ENDOCANNABINOID; HYPOXIA INDUCIBLE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PSYCHOTROPIC AGENT; RIMONABANT; SB 203528; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANXIETY DISORDER; APOPTOSIS; ATHEROSCLEROSIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RESEARCH; CEREBROVASCULAR ACCIDENT; DRUG STRUCTURE; DRUG TOLERABILITY; GLAUCOMA; GLIOMA; HEART INFARCTION; HOPE; HUMAN; HUNTINGTON CHOREA; HYPERTENSION; MOOD; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; NONHUMAN; OBESITY; OSTEOPOROSIS; PAIN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; CANNABINOIDS; HUMANS; NEOPLASMS;

EID: 84959207549     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.02.010     Document Type: Review

References (212)

1. F. Afaq, S. Sarfaraz, D. Syed, N. Khan, A. Malik., H. Bailey, and et al. Cannabinoid Receptors as a Target for Therapy of Ovarian Cancer 2006 AACR Meeting Washington, DC
2. A. Ameri The effects of cannabinoids on the brain Prog. Neurobiol. 58 4 1999 315 348
3. C. Andradas, M.M. Caffarel, E. Perez-Gomez, M. Salazar, M. Lorente, G. Velasco, and et al. The orphan G protein-coupled receptor GPR55 promotes Cancer cell proliferation via ERK Oncogene 30 2 2011 245 252
4. J.L. Armstrong, D.S. Hill, C.S. McKee, S. Hernandez-Tiedra, M. Lorente, L. Lopez-Valero, and et al. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death J. Invest. Dermatol. 135 6 2015 1629 1637
5. G. Aviello, B. Romano, F. Borrelli, R. Capasso, L. Gallo, F. Piscitelli, and et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon Cancer J. Mol. Med. 90 8 2012 925 934
6. C. Benito, E. Nunez, M.R. Pazos, R.M. Tolon, and J. Romero The endocannabinoid system and Alzheimer disease Mol. Neurobiol. 36 1 2007 75 81
7. C. Benito, E. Nunez, R.M. Tolon, E.J. Carrier, A. Rabano, C.J. Hillard, and et al. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer disease brains J. Neurosci. 23 35 2003 11136 11141
8. A.H. Benz, C. Renne, E. Maronde, M. Koch, U. Grabiec, S. Kallendrusch, and et al. Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma PLoS One 8 2013 e81675
9. G. Bidaux, M. Roudbaraki, C. Merle, A. Crépin, P. Delcourt, C. Slomianny, and et al. Evidence for specific TRPM8 expression in Human prostate secretory epithelial cells: functional androgen receptor requirement Endocr. Relat. Cancer 12 2 2005 367 382
10. G. Bidaux, M. Flourakis, S. Thebault, A. Zholos, B. Beck, D. Gkika, and et al. Prostate cell differentiation status determines transient receptor potential melastatin member 8 channel subcellular localization and function J. Clin. Invest. 117 6 2007 1647 1657
11. M. Bifulco, C. Laezza, G. Portella, M. Vitale, P. Orlando, L. De Petrocellis, and V. Di Marzo Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth FASEB J. 15 14 2001 2745-7
12. M. Bifulco, A.M. Malfitano, S. Pisanti, and C. Laezza Endocannabinoids in endocrine and related tumours Endocr. Relat. Cancer 15 2 2008 391 408
13. C. Blazquez, M.L. Casanova, A. Planas, T. Gomez Del Pulgar, C. Villanueva, M.J. Fernandez-Acenero, and et al. Inhibition of tumor angiogenesis by cannabinoids FASEB J. 17 3 2003 529 531
14. C. Blazquez, A. Carracedo, L. Barrado, P.J. Real, J.L. Fernandez-Luna, G. Velasco, and et al. Cannabinoid receptors as novel targets for the treatment of melanoma FASEB J. 20 14 2006 2633 2635
15. R. Blevins, and D. Smith Effects of delta-9-tetrahydrocannabinol on cultured HeLa cell growth and development Growth 44 1980 133 134
16. R.D. Blevins, and D.P. Smith Effects of delta-9-tetrahydrocannabinol on cultured HeLa cell growth and development Growth 44 2 1980 133-8
17. C.S. Breivogel, G. Griffin, V. Di Marzo, and B.R. Martin Evidence for a New G protein-coupled cannabinoid receptor in mouse brain Mol. Pharmacol. 60 1 2001 155 163
18. N.E. Buckley The peripheral cannabinoid receptor knockout mice: an update Br. J. Pharmacol. 153 2 2008 309 318
19. G.A. Cabral, and L. Griffin-Thomas Cannabinoids as therapeutic agents for ablating neuroinflammatory disease Endocr. Metab. Immune Disord. Drug Targets 8 3 2008 159 172
20. M.M. Caffarel, G. Moreno-Bueno, C. Cerutti, J. Palacios, M. Guzman, F. Mechta-Grigoriou, and et al. JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on Human breast Cancer cells Oncogene 27 37 2008 5033 5044
21. M.M. Caffarel, C. Andradas, E. Mira, E. Perez-Gomez, C. Cerutti, G. Moreno-Bueno, and et al. Cannabinoids reduce ErbB2-driven breast Cancer progression through Akt inhibition Mol. Cancer 9 2010 196
22. P. Canoll, and J.E. Goldman The interface between glial progenitors and gliomas Acta Neuropathol. 116 5 2008 465 477
23. A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzman, G. Velasco, and et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes Cancer Res. 66 13 2006 6748 6755
24. A. Carracedo, M. Lorente, A. Egia, C. Blazquez, S. Garcia, V. Giroux, and et al. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells Cancer Cell 9 4 2006 301 312
25. M.L. Casanova, C. Blazquez, J. Martinez-Palacio, C. Villanueva, M.J. Fernandez-Acenero, J.W. Huffman, and et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors J. Clin. Invest. 111 1 2003 43 50
26. A. Chakrabarti, E.S. Onaivi, and G. Chaudhuri Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein DNA Seq. 5 6 1995 385 388
27. L. Chen, Y. Li, L. Li, and Y. Qiu Endocannabinoid and ceramide levels are altered in patients with colorectal Cancer Oncol. Rep. 34 1 2015 447 454
28. S.C. Chung, P. Hammarsten, A. Josefsson., P. Stattin, T. Granfors, L. Egevad, and et al. A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate Cancer Eur. J. Cancer 45 1 2009 174 182
29. F. Cianchi, L. Papucci, N. Schiavone, M. Lulli, L. Magnelli, M.C. Vinci, and et al. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide DE novo synthesis in colon Cancer cells Clin. Cancer Res. 14 23 2008 7691 7700
30. S. Cole, K. Sparks, K. Fraser, D. Loe, C. Grant, G. Wilson, and et al. Pharmacological characterization of multidrug resistant MRP-transfected Human tumor cells Cancer Res. 54 1994 5902 5910
31. G. Czifra, A. Varga, K. Nyeste, R. Marincsák, B. Tóth, I. Kovács, and et al. Increased expressions of cannabinoid receptor-1 and transient receptor potential vanilloid-1 in Human prostate carcinoma J. Cancer Res. Clin. Oncol. 135 4 2009 507 514
32. S. Das, B. Paria, I. Chakraborty, and S. Dey Cannabinoid ligand-receptor signaling in the mouse uterus Proc. Natl. Acad. Sci. USA 92 10 1995 4332 4336
33. L. De Petrocellis, and V. Di Marzo Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels J. Neuroimmune Pharmacol. 5 1 2010 103 121
34. L. De Petrocellis, D. Melck, A. Palmisano, T. Bisogno, C. Laezza, M. Bifulco, and et al. The endogenous cannabinoid anandamide inhibits Human breast Cancer cell proliferation Proc. Natl. Acad. Sci. USA 95 14 1998 8375 8380
35. L. De Petrocellis, V. Vellani, A. Schiano-Moriello, P. Marini, P. Magherini, P. Orlando, and et al. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 J. Pharmacol. Exp. Ther. 325 3 2008 1007 1015
36. L. De Petrocellis, A. Ligresti, A. Schiano Moriello, M. Allarà, T. Bisogno, S. Petrosino, and et al. Effects of cannabinoids and cannabinoid-enriched cannabis extracts on TRP channels and endocannabinoid metabolic enzymes Br. J. Pharmacol. 163 7 2011 1479 1494
37. L. De Petrocellis, A. Ligresti, A. Schiano Moriello, M. Iappelli, R. Verde, C. Stott, and et al. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms Br. J. Pharmacol. 168 1 2013 79 102
38. D.G. Demuth, and A. Molleman Cannabinoid signalling Life Sci. 78 6 2006 549 563
39. M. Dennedy, A. Friel, D. Houlihan, V. Broderick, T. Smith, and J. Morrison Cannabinoids and the Human uterus during pregnancy Am. J. Obstet. Gynecol. 190 1 2004 2 9
40. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, and et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 5090 1992 1946 1949
41. V. Di Marzo, T. Bisogno, and L. De Petrocellis Anandamide: some like it hot Trends Pharmacol. Sci. 22 7 2001 346 349
42. V. Di Marzo, C.S. Breivogel, Q. Tao, D.T. Bridgen, R.K. Razdan, A.M. Zimmer, and et al. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain J. Neurochem. 75 6 2000 2434 2444
43. V.P. Dixit, V.N. Sharma, and N.K. Lohiya The effect of chronically administered cannabis extract on the testicular function of mice Eur. J. Pharmacol. 26 1 1974 111 114
44. S. Ek, C.M. Hogerkorp, M. Dictor, M. Ehinger, and C.A. Borrebaeck Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal Human B cells Cancer Res. 62 15 2002 4398 4405
45. M. Elbaz, M.W. Nasser, J. Ravi, N.A. Wani, D.K. Ahirwar, H. Zhao, S. Oghumu, A.R. Satoskar, K. Shilo, W.E. Carson, and R.K. Ganju Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast Cancer Mol. Oncol. 9 4 2015 906 919
46. A. Ellert-Miklaszewska, B. Kaminska, and L. Konarska Cannabinoids down-regulate PI3K/Akt and erk signalling pathways and activate proapoptotic function of bad protein Cell Signal 17 1 2005 25 37
47. A. Ellert-Miklaszewska, W. Grajkowska, K. Gabrusiewicz, B. Kaminska, and L. Konarska Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors Brain Res. 1137 1 2007 161 169
48. N. Farsandaj, M.H. Ghahremani, and S.N. Ostad Role of cannabinoid and vanilloid receptors in invasion of Human breast carcinoma cells J. Environ. Pathol. Toxicol. Oncol. 31 4 2012 377 387
49. J. Fernandez-Ruiz, J. Romero, G. Velasco, R.M. Tolon, J.A. Ramos, and M. Guzman Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol. Sci. 28 1 2007 39 45
50. M. Flens, G. Zaman, P. Van der Valk, M. Izquierdo, A. Schroeijers, G. Scheffer, and et al. Tissue distribution of the multidrug resistance protein Am. J. Pathol. 148 4 1996 1237 1247
51. I. Galve-Roperh, C. Sanchez, M. Cortes, T. Del Pulgar, M. Izquierdo, and M. Guzman Anti-tumoural action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation Nat. Med. 6 2000 313 319
52. Y. Gaoni, and R. Mechoulam Hashish II. the structure and synthesis of cannabigerol, a New hashish constituent Proc. Chem. Soc. 1964 82
53. Y. Gaoni, and R. Mechoulam Isolation, structure, and partial synthesis of an active constituent of hashish J. Am. Chem. Soc. 86 1964 1646 1647
54. Y. Gaoni, and R. Mechoulam Hashish II. the structure and synthesis of cannabigerol, a New hashish constituent Proc. Chem. Soc. 1964 82
55. Y. Gaoni, and R. Mechoulam Cannabichromene, a new active principle in hashish Chem. Commun. 1 1966 20 21
56. B. Gardner, L.X. Zhu, S. Sharma, D.P. Tashkin, and S.M. Dubinett Methanandamide increases COX-2 expression and tumor growth in murine lung Cancer FASEB J. 17 14 2003 2157 2159
57. M. Glass, and J.K. Northup Agonist selective regulation of g proteins by cannabinoid CB1 and CB2 receptors Mol. Pharmacol. 56 6 1999 1362 1369
58. M. Glass, R.L. Faull, and M. Dragunow Loss of cannabinoid receptors in the substantia nigra in Huntington disease Neuroscience 56 3 1993 523 527
59. T. Gomez Del Pulgar, M.L. De Ceballos, M. Guzman, and G. Velasco Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway J. Biol. Chem. 277 39 2002 36527 36533
60. A. Greenhough, H.A. Patsos, A.C. Williams, and C. Paraskeva The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal Cancer cells Int. J. Cancer 121 10 2007 2172 2180
61. C. Grimaldi, S. Pisanti, C. Laezza, A.M. Malfitano, A. Santoro, M. Vitale, and et al. Anandamide inhibits adhesion and migration of breast Cancer cells Exp. Cell Res. 312 4 2006 363 373
62. F. Grotenhermen The toxicology of cannabis and cannabis prohibition Chem. Biodivers. 4 8 2007 1744 1769
63. M. Guida, A. Ligresti, D. De Filippis, A. D'Amico, S. Petrosino, M. Cipriano, and et al. The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma Endocrinology 151 3 2010 921 928
64. K. Gustafsson, B. Christensson, B. Sander, and J. Flygare Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma MolPharmacol. 70 5 2006 1612-20
65. M. Guzmán Cannabinoids: potential anticancer agents Nat. Rev. Cancer 3 10 2003 745 755 (Review)
66. M. Guzman, I. Galve-Roperh, and C. Sanchez Ceramide: a new second messenger of cannabinoid action Trends Pharmacol. Sci. 22 1 2001 19 22
67. M. Guzman, C. Sanchez, and I. Galve-Roperh Cannabinoids and cell fate Pharmacol. Ther. 95 2 2002 175 184
68. M. Guzman, M.J. Duarte, C. Blazquez, J. Ravina, M.C. Rosa, I. Galve-Roperh, and et al. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme Br. J. Cancer 95 2 2006 197 203
69. M.C. Gye, H.H. Kang, and H.J. Kang Expression of cannabinoid receptor 1 in mouse testes Arch. Androl. 51 3 2005 247 255
70. O. Habayeb, A. Taylor, S. Bell, D. Taylor, and J. Konje Expression of the endocannabinoid system in Human first trimester placenta and its role in trophoblast proliferation Endocrinology 149 10 2008 5052 5060
71. S. Hart, O.M. Fischer, and A. Ullrich Cannabinoids induce Cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor Cancer Res. 64 6 2004 1943 1950
72. M. Haustein, R. Ramer, M. Linnebacher, K. Manda, and B. Hinz Cannabinoids increase lung Cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1 Biochem. Pharmacol. 92 2 2014 312 325
73. J. Held-Feindt, L. Dorner, G. Sahan, H.M. Mehdorn, and R. Mentlein Cannabinoid receptors in Human astroglial tumors J. Neurochem. 98 3 2006 886 893
74. R. Helliwell, L. Chamley, K. Blake-Palmer, M. Mitchell, J. Wu, C. Kearn, and et al. Characterization of the endocannabinoid system in early Human pregnancy J. Clin. Endocrinol. Metab. 89 10 2004 5168 5174
75. S. Henshall, D. Afar, J. Hiller, L. Horvath, D. Quinn, K. Rasiah, and et al. Survival analysis of genome-wide gene expression profiles of prostate cancers identifies New prognostic targets of disease relapse Cancer Res. 63 14 2003 4196 4203
76. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. De Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J. Neurosci. 11 2 1991 563 583
77. A.F. Hoffman, N. Laaris, M. Kawamura, S.A. Masino, and C.R. Lupica Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors J. Neurosci. 30 2 2010 545 555
78. M.L. Holland, J.D. Allen, and J.C. Arnold Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1) Eur. J. Pharmacol. 591 1-3 2008 128 131
79. M.L. Holland, D.T. Lau, J.D. Allen, and J.C. Arnold The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids Br. J. Pharmacol. 152 5 2007 815 824
80. J. Hooijberg, H. Broxterman, M. Kool, Y. Assaraf, G. Peters, P. Noordhuis, and et al. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2 Cancer Res. 59 1999 2532 2535
81. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, W.A. Devane, and et al. A comprehensive update on cannabinoid receptors and their biochemistry and pharmacology. international union of pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev. 54 2 2002 161 202
82. M.J. Hurley, D.C. Mash, and P. Jenner Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian Human brain J. Neural Transm. 110 11 2003 1279 1288
83. K. Ihenetu, A. Molleman, M.E. Parsons, and C.J. Whelan Inhibition of interleukin-8 release in the Human colonic epithelial cell line HT-29 by cannabinoids Eur. J. Pharmacol. 458 1-2 2003 207 215
84. T.C. Islam, A.C. Asplund, J.M. Lindvall, L. Nygren, J. Liden, E. Kimby, and et al. High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of cyclin D1 in mantle cell lymphoma Leukemia 17 9 2003 1880 1890
85. T. Iuvone, D. De Filippis, A. Di Spiezio Sardo, A. D'Amico, S. Simonetti, S. Sparice, and et al. Selective CB2 up-regulation in women affected by endometrial inflammation J. Cell Mol. Med. 12 2 2008 661 670
86. A.A. Izzo, and M. Camilleri Cannabinoids in intestinal inflammation and Cancer Pharmacol. Res. 60 2 2009 117 125
87. S.O. Jacobsson, E. Rongård, M. Stridh, G. Tiger, and C.J. Fowler Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability BiochemPharmacol. 60 12 2000 1807 1813
88. C.K. Jung, W.K. Kang, J.M. Park, H.J. Ahn, S.W. Kim, S.O.H. Taek, and et al. Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal Cancer Oncol. Lett. 5 3 2013 870 876
89. E. Karászi, K. Jakab, L. Homolya, G. Szakács, Z. Holló, B. Telek, and et al. Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia Br. J. Haematol. 112 2001 308 314
90. D. Keppler, I. Leier, and G. Jedlitschky Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2 Biol. Chem. 378 8 1997 789 791
91. J.A. Kim, K.B. Cho, M.R. Kim, B.C. Park, S.K. Kim, M.Y. Lee, and et al. Decreased production of vascular endothelial growth factor in adriamycin-resistant breast Cancer cells Cancer Lett. 268 2 2008 225 232
92. M.R. Kim, H.S. Choi, J.W. Yang, B.C. Park, J.A. Kim, and K.W. Kang Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast Cancer cells: role of Pin1 overexpression Mol. Cancer Ther. 8 8 2009 2163 2171
93. N.M. Kogan Cannabinoids and Cancer Mini Rev. Med. Chem. 5 10 2005 941 952
94. R.C. Kolodny, W.H. Masters, R.M. Kolodner, and G. Toro Depression of plasma testosterone levels after chronic intensive marihuana use N. Engl. J. Med. 290 16 1974 872 874
95. F.R. Kreitzer, and N. Stella The therapeutic potential of novel cannabinoid receptors Pharmacol. Ther. 122 2 2009 83 96
96. V. Lehen'kyi, and N. Prevarskaya Oncogenic TRP channels Adv. Exp. Med. Biol. 704 2011 929 945
97. S. Liberati, M.B. Morelli, M. Nabissi, M. Santoni, and G. Santoni Oncogenic and anti-oncogenic effects of transient receptor potential channels Curr. Top. Med. Chem. 13 3 2013 344 366
98. A. Ligresti, T. Bisogno, I. Matias, L. De Petrocellis, M.G. Cascio, V. Cosenza, and et al. Possible endocannabinoid control of colorectal Cancer growth Gastroenterology 125 3 2003 677 687
99. A. Ligresti, A.S. Moriello, K. Starowicz, I. Matias, S. Pisanti, L. De Petrocellis, and et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on Human breast carcinoma J. Pharmacol. Exp. Ther. 318 3 2006 1375 1387
100. J.A. López-Moreno, A. López-Jiménez, M.A. Gorriti, and F.R. de Fonseca Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors Curr Drug Targets 11 4 2010 406-28. Review
101. M. Maccarrone, T. Lorenzon, M. Bari, G. Melino, and A. Finazzi-Agro Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors J Biol Chem. 275 41 2000 31938-45
102. M. Maccarrone, S. Cecconi, G. Rossi, N. Battista, R. Pauselli, and A. Finazzi-Agrò Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating Hormone in mouse Sertoli cells Endocrinology 144 1 2003 20 28
103. S. Maione, T. Bisogno, V. De Novellis, E. Palazzo, L. Cristino, M. Valenti, and et al. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors J. Pharmacol. Exp. Ther. 316 3 2006 969 982
104. S. Maione, B. Costa, F. Piscitelli, E. Morera, M. De Chiaro, F. Comelli, and et al. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics Pharmacol. Res. 76 2013 98 105
105. S. Malagarie-Cazenave, N. Olea-Herrero, D. Vara, and I. Díaz-Laviada Capsaicin, a component of red peppers, induces expression of androgen receptor via PI3K and MAPK pathways in prostate LNCaP cells FEBS Lett. 583 1 2009 141 147
106. S. Malagarie-Cazenave, N. Olea-Herrero, D. Vara, C. Morell, and I. Díaz-Laviada The vanilloid capsaicin induces IL-6 secretion in prostate PC-3 Cancer cells Cytokine 54 3 2011 330 337
107. A.M. Malfitano, E. Ciaglia, G. Gangemi, P. Gazzerro, C. Laezza, and M. Bifulco Update on the endocannabinoid system as an anticancer target Expert Opin. Ther. Targets 15 3 2011 297 308
108. A. Mallat, and S. Lotersztajn Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis Diabetes Metab. 34 6 Pt 2 2008 680 684
109. E. Martinez-Martinez, I. Gomez, P. Martin, A. Sanchez, L. Roman, E. Tejerina, F. Bonilla, A.G. Merino, A.G. Herreros, M. Provencio, and J.M. García Cannabinoids receptor type 2, CB2, expression correlates with Human colon Cancer progression and predicts patient survival Oncoscience 2 2 2015 131 141
110. P. Massi, A. Vaccani, S. Ceruti, A. Colombo, M.P. Abbracchio, and D. Parolaro Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on Human glioma cell lines J. Pharmacol. Exp. Ther. 308 3 2004 838 845
111. P. Massi, A. Vaccani, S. Bianchessi, B. Costa, P. Macchi, and D. Parolaro The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in Human glioma cells Cell Mol. Life Sci. 63 17 2006 2057 2066
112. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 6284 1990 561 564
113. S.D. McAllister, L. Soroceanu, and P.Y. Desprez The anti-tumour activity of plant-derived non-psychoactive cannabinoids J. Neuroimmune Pharmacol. 10 2015 255 267
114. R.J. McKallip, C. Lombard, M. Fisher, B.R. Martin, S. Ryu, S. Grant, P.S. Nagarkatti, and M. Nagarkatti Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Blood 100 2 2002 627-34
115. R.J. McKallip, M. Nagarkatti, and P.S. Nagarkatti Delta-9-tetrahydrocannabinol enhances breast Cancer growth and metastasis by suppression of the antitumor immune response J. Immunol. 174 6 2005 3281 3289
116. R. Mechoulam, D. Panikashvili, and E. Shohami Cannabinoids and brain injury: therapeutic implications Trends Mol. Med. 8 2 2002 58 61
117. D. Melck, D. Rueda, I. Galve-Roperh, L. De Petrocellis, M. Guzman, and V. Di Marzo Involvement of the cAMP/protein kinase a pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in Human breast Cancer cells FEBS Lett. 463 3 1999 235 240
118. D. Melck, L. De Petrocellis, P. Orlando, T. Bisogno, C. Laezza, M. Bifulco, and et al. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of Human breast and prostate Cancer cell proliferation Endocrinology 141 1 2000 118 126
119. E.M. Messalli, F. Grauso, R. Luise, A. Angelini, and R. Rossiello Cannabinoid receptor type 1 immunoreactivity and disease severity in Human epithelial ovarian tumors Am. J. Obstet. Gynecol. 211 3 2014 234.e231-234.e236
120. M. Mimeault, N. Pommery, N. Wattez, C. Bailly, and J.P. Henichart Anti-proliferative and apoptotic effects of anandamide in Human prostatic Cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production Prostate 56 1 2003 1 12
121. E. Molina-Holgado, J.M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, J. Borrell, and et al. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling J. Neurosci. 22 22 2002 9742 9753
122. M. Mon, R. Jansing, S. Doggett, J. Stein, and G. Stein Influence of delta9-tetrahydrocannabinol on cell proliferation and macromolecular biosynthesis in Human cells Biochem. Pharmacol. 27 13 1978 1759 1765
123. P. Morales, S. Blasco-Benito, C. Andradas, M. Gómez-Cañas, J.M. Flores, P. Goya, J. Fernández-Ruiz, C. Sánchez, and N. Jagerovic Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast Cancer J. Med. Chem. 58 5 2015 2256 2264
124. E. Moreno, C. Andradas, M. Medrano, M.M. Caffarel, E. Perez-Gomez, S. Blasco-Benito, and et al. Targeting CB2-GPR55 receptor heteromers modulates Cancer cell signaling J. Biol. Chem. 289 32 2014 21960 21972
125. N. Morioka, J.M. Abdin, K. Morita, T. Kitayama, Y. Nakata, and T. Dohi The regulation of glycine transporter GLYT1 is mainly mediated by protein kinase Calpha in C6 glioma cells Neurochem. Int. 53 6-8 2008 248 254
126. B. Mukhopadhyay, K. Schuebel, P. Mukhopadhyay, R. Cinar, G. Godlewski, K. Xiong, and et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms Hepatology 61 5 2015 1615 1626
127. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 6441 1993 61 65
128. A.E. Munson, L.S. Harris, M.A. Friedman, W.L. Dewey, and R.A. Carchman Antineoplastic activity of cannabinoids J. Natl. Cancer Inst. 55 3 1975 597 602
129. M.W. Nasser, Z. Qamri, Y.S. Deol, D. Smith, K. Shilo, X. Zou, and et al. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast Cancer growth and invasion PLoS One 6 9 2011 e23901
130. M. Norris, S. Bordow, G. Marshall, P. Haber, S. Cohn, and M. Haber Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma N. Engl. J. Med. 334 1996 231 238
131. M. Notarnicola, C. Messa, A. Orlando, M. Bifulco, C. Laezza, P. Gazzerro, and et al. Estrogenic induction of cannabinoid CB1 receptor in Human colon Cancer cell lines Scand. J. Gastroenterol. 43 1 2008 66 72
132. E. Nunez, C. Benito, M.R. Pazos, A. Barbachano, O. Fajardo, S. Gonzalez, and et al. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the Human brain: an immunohistochemical study Synapse 53 4 2004 208 213
133. N. Olea-Herrero, D. Vara, S. Malagarie-Cazenave, and I. Diaz-Laviada Inhibition of Human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2 Br. J. Cancer 101 6 2009 940 950
134. A. Ortega, E. Rangel-López, A. Hidalgo-Miranda, A. Morales, E. Ruiz-García, and A. Meneses-García On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines Toxicol Vitr. 29 7 2015 1941 1951
135. P. Pacher, S. Batkai, and G. Kunos The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol. Rev. 58 3 2006 389 462
136. B. Paria, H. Song, X. Wang, P. Schmid, R. Krebsbach, H. Schmid, and et al. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation J. Biol. Chem. 276 23 2001 20523 20528
137. B. Park, H. Gibbons, M. Mitchell, and M. Glass Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the Human placenta Placenta 24 10 2003 990 995
138. H.A. Patsos, D.J. Hicks, R.R. Dobson, A. Greenhough, N. Woodman, J.D. Lane, and et al. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 Gut 54 12 2005 1741 1750
139. E. Perez-Gomez, C. Andradas, J.M. Flores, M. Quintanilla, J.M. Paramio, M. Guzman, and et al. The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in Human squamous cell carcinomas Oncogene 32 20 2013 2534 2542
140. R.G. Pertwee The pharmacology of cannabinoid receptors and their ligands: an overview Int. J. Obes. 30 Suppl 1 2006 S13 S18
141. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br. J. Pharmacol. 156 3 2009 397 411
142. R.G. Pertwee, R.A. Ross, S.J. Craib, and A. Thomas (-)-Cannabidiol Antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens Eur. J. Pharmacol. 456 1-3 2002 99 106
143. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, M.R. Elphick, and et al. International union of BASIC and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 Pharmacol. Rev. 62 4 2010 588 631
144. G. Petersen, B. Moesgaard, P.C. Schmid, H.H. Schmid, H. Broholm, M. Kosteljanetz, and et al. Endocannabinoid metabolism in Human glioblastomas and meningiomas compared to Human non-tumour brain tissue J. Neurochem. 93 2 2005 299 309
145. R. Pineiro, T. Maffucci, and M. Falasca The putative cannabinoid receptor GPR55 defines a novel autocrine loop in Cancer cell proliferation Oncogene 30 2 2011 142 152
146. S. Pisanti, P. Picardi, A. D'Alessandro, C. Laezza, and M. Bifulco The endocannabinoid signaling system in Cancer Trends Pharmacol. Sci. 34 5 2013 273 282
147. R. Portenoy, E. Ganae-Motan, S. Allende, R. Yanagihara, L. Shaiova, S. Weinstein, and et al. Nabiximols for opioid-treated Cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial J. Pain 13 5 2012 438 449
148. A.C. Porter, and C.C. Felder The endocannabinoid nervous system: unique opportunities for therapeutic intervention Pharmacol. Ther. 90 1 2001 45 60
149. A. Preet, R.K. Ganju, and J.E. Groopman Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung Cancer cell migration in vitro as well as its growth and metastasis in vivo Oncogene 27 3 2008 339 346
150. A. Preet, Z. Qamri, M.W. Nasser, A. Prasad, K. Shilo, X. Zou, and et al. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung Cancer growth and metastasis Cancer Prev. Res. 4 1 2011 65 75
151. M.C. Proto, P. Gazzerro, L. Di Croce, A. Santoro, A.M. Malfitano, S. Pisanti, and et al. Interaction of endocannabinoid system and steroid hormones in the control of colon Cancer cell growth J. Cell Physiol. 227 1 2012 250 258
152. Z. Qamri, A. Preet, M.W. Nasser, C.E. Bass, G. Leone, S.H. Barsky, and et al. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast Cancer Mol. Cancer Ther. 8 11 2009 3117 3129
153. N. Qin, M. Neeper, Y. Liu, T. Hutchinson, M. Lubin, and C. Flores TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons J. Neurosci. 28 24 2008 6231 6238
154. R. Ramer, and B. Hinz Inhibition of Cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1 J. Natl. Cancer Inst. 100 1 2008 59 69
155. R. Ramer, J. Merkord, H. Rohde, and B. Hinz Cannabidiol inhibits Cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1 Biochem. Pharmacol. 79 7 2010 955 966
156. R. Ramer, S. Fischer, M. Haustein, K. Manda, and B. Hinz Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung Cancer cells Biochem. Pharmacol. 91 2 2014 202 216
157. R. Ramer, K. Heinemann, J. Merkord, H. Rohde, A. Salamon, M. Linnebacher, and et al. COX-2 and PPAR-gamma confer cannabidiol-induced apoptosis of Human lung Cancer cells Mol. Cancer Ther. 12 1 2013 69 82
158. E.K. Richfield, and M. Herkenham Selective vulnerability in Huntington disease: preferential loss of cannabinoid receptors in lateral globus pallidus Ann. Neurol. 36 4 1994 577 584
159. P. Robson Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a New cannabinoid medicine Expert Opin. Drug Saf. 10 5 2011 675 685
160. J. Romero, F. Berrendero, L. Garcia-Gil, P. De la Cruz, J.A. Ramos, and J.J. Fernandez-Ruiz Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5′O-(thio)-triphosphate binding in the basal ganglia of aged rats Neuroscience 84 4 1998 1075 1083
161. R.A. Ross Anandamide and vanilloid TRPV1 receptors Br. J. Pharmacol. 140 5 2003 790 801
162. M. Rossato, F. Ion Popa, M. Ferigo, G. Clari, and C. Foresta Human sperm express cannabinoid receptor CB1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function J. Clin. Endocrinol. Metab. 90 2 2005 984 991
163. V. Rubovitch, M. Gafni, and Y. Sarne The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+flux into N18TG2 neuroblastoma cells Brain Res. Mol. 120 2 2004 138 144
164. L. Ruiz, A. Miguel, and I. Diaz-Laviada Delta9-tetrahydrocannabinol induces apoptosis in Human prostate PC-3 cells via a receptor-independent mechanism FEBS Lett. 458 3 1999 400 404
165. L. Ruiz-Llorente, M.G. Sanchez, M.J. Carmena, J.C. Prieto, M. Sanchez-Chapado, A. Izquierdo, and et al. Expression of functionally active cannabinoid receptor CB1 in the Human prostate gland Prostate 54 2 2003 95 102
166. A. Sánchez, M. Sánchez, S. Malagarie-Cazenave, N. Olea, and I. Díaz-Laviada Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin Apoptosis 11 1 2006 89 99
167. S. Sailler, K. Schmitz, E. Jager, N. Ferreiros, S. Wicker, K. Zschiebsch, and et al. Regulation of circulating endocannabinoids associated with Cancer and metastases in mice and humans Oncoscience 1 4 2014 272 282
168. C. Sánchez, M.L. De Ceballos, T. Gomez del Pulgar, D. Rueda, C. Corbacho, G. Velasco, and et al. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor Cancer Res. 61 15 2001 5784 5789
169. C. Sánchez, D. Rueda, B. Segui, I. Galve-Roperh, T. Levade, and M. Guzman The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin Hydrolysis through the adaptor protein Fan Mol. Pharmacol. 59 5 2001 955 959
170. M. Sánchez, A. Sanchez, B. Collado, S. Malagarie-Cazenave, N. Olea, M. Carmena, and et al. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate Cancer cells and in Human prostate tissue Eur. J. Pharmacol. 515 1-3 2005 20 27
171. M.G. Sanchez, A.M. Sanchez, L. Ruiz-Llorente, and I. Diaz-Laviada Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells FEBS Lett. 555 3 2003 561 566
172. A. Santoro, S. Pisanti, C. Grimaldi, A.A. Izzo, F. Borrelli, M.C. Proto, and et al. Rimonabant inhibits Human colon Cancer cell growth and reduces the formation of precancerous lesions in the mouse colon Int. J. Cancer 125 5 2009 996 1003
173. S. Sarfaraz, F. Afaq, V.M. Adhami, and H. Mukhtar Cannabinoid receptor as a novel target for the treatment of prostate Cancer Cancer Res. 65 5 2005 1635 1641
174. S. Sarfaraz, F. Afaq, V.M. Adhami, A. Malik, and H. Mukhtar Cannabinoid receptor agonist-induced apoptosis of Human prostate Cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest J. Biol. Chem. 281 51 2006 39480 39491
175. S. Sarfaraz, V.M. Adhami, D.N. Syed, F. Afaq, and H. Mukhtar Cannabinoids for Cancer treatment: progress and promise Cancer Res. 68 2 2008 339 342
176. D. Sarnataro, S. Pisanti, A. Santoro, P. Gazzerro, A.M. Malfitano, C. Laezza, and et al. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits Human breast Cancer cell proliferation through a lipid raft-mediated mechanism Mol. Pharmacol. 70 4 2006 1298 1306
177. M. Schley, S. Stander, J. Kerner, P. Vajkoczy, G. Schupfer, M. Dusch, and et al. Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans Brain Res. Bull. 79 5 2009 333 337
178. K.A. Scott, A.G. Dalgleish, and W.M. Liu The combination of cannabidiol and Delta9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model Mol. Cancer Ther. 13 12 2014 2955 2967
179. D. Shire, B. Calandra, M. Rinaldi-Carmona, D. Oustric, B. Pessegue, O. Bonnin-Cabanne, and et al. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor Biochim. Biophys. Acta 1307 2 1996 132 136
180. A. Shrivastava, P.M. Kuzontkoski, J.E. Groopman, and A. Prasad Cannabidiol induces programmed cell death in breast Cancer cells by coordinating the cross-talk between apoptosis and autophagy Mol. Cancer Ther. 10 2011 1161 1172
181. S.D. Skaper, A. Buriani, R. Dal Toso, L. Petrelli, S. Romanello, L. Facci, and et al. The Aliamide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons Proc. Natl. Acad. Sci. USA 93 9 1996 3984 3989
182. E.K. Sloan, K.L. Stanley, and R.L. Anderson Caveolin-1 inhibits breast Cancer growth and metastasis Oncogene 23 47 2004 7893 7897
183. D. Smart, and J.C. Jerman Anandamide: an endogenous activator of the vanilloid receptor Trends Pharmacol. Sci. 21 4 2000 134 Apr.
184. M. Solinas, P. Massi, V. Cinquina, M. Valenti, D. Bolognini, M. Gariboldi, and et al. Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect PLoS One 8 10 2013 e76918
185. N. Stella Cannabinoid signaling in glial cells Glia 48 4 2004 267 277
186. J.M. Sullivan Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids Learn. Mem. 7 3 2000 132 139
187. Y. Sun, and A. Bennett Cannabinoids: a new group of agonists of PPARs PPAR Res. 2007 2007 23513
188. D. Thapa, J.S. Lee, S.W. Heo, Y.R. Lee, K.W. Kang, M.K. Kwak, and et al. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis Eur. J. Pharmacol. 650 1 2011 64 71
189. K. Tomiyama, and M. Funada Cytotoxicity of synthetic cannabinoids found in 'spice' products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line Toxicol. Lett. 207 2011 12 17
190. S. Torres, M. Lorente, F. Rodriguez-Fornes, S. Hernandez-Tiedra, M. Salazar, E. Garcia-Taboada, and et al. A combined preclinical therapy of cannabinoids and temozolomide against glioma Mol. Cancer Ther. 10 1 2011 90 103
191. L. Tsavaler, M. Shapero, S. Morkowski, and R. Laus Trp-p8, a novel prostate-specific gene, is up-regulated in prostate Cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins Cancer Res. 61 9 2001 3760 3769
192. K. Tsou, S. Brown, M.C. Sanudo-Pena, K. Mackie, and J.M. Walker Immunohistochemical distribution of cannabinoid CB1 receptors in the rat Central nervous system Neuroscience 83 2 1998 393 411
193. A. Vaccani, P. Massi, A. Colombo, T. Rubino, and D. Parolaro Cannabidiol inhibits Human glioma cell migration through a cannabinoid receptor-independent mechanism Br. J. Pharmacol. 144 8 2005 1032 1036
194. O. Valverde, M. Karsak, and A. Zimmer Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice Handb. Exp. Pharmacol. 168 2005 117 145
195. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, and et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 5746 2005 329 332
196. D. Vara, M. Salazar, N. Olea-Herrero, M. Guzman, G. Velasco, and I. Diaz-Laviada Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy Cell Death Differ. 18 7 2011 1099 1111
197. G. Velasco, C. Sanchez, and M. Guzman Towards the use of cannabinoids as antitumour agents Nat. Rev. Cancer 12 6 2012 436 444
198. G. Velasco, S. Hernandez-Tiedra, D. Davila, and M. Lorente The use of cannabinoids as anti-cancer agents Prog. Neuro-Psychopharmacol. Biol. Psychiatry 64 2015 259 266
199. L. Velasco, L. Ruiz, M.G. Sanchez, and I. Diaz-Laviada Delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1 Eur. J. Biochem. 268 3 2001 531 535
200. D. Wang, H. Wang, W. Ning, M.G. Backlund, S.K. Dey, and R.N. DuBois Loss of cannabinoid receptor 1 accelerates intestinal tumor growth Cancer Res. 68 15 2008 6468 6476
201. H. Wang, Y. Guo, D. Wang, P. Kingsley, L. Marnett, S. Das, and et al. Aberrant cannabinoid signaling impairs oviductal transport of embryos Nat. Med. 10 10 2004 1074 1080
202. A.M. Wasik, L. Nygren, S. Almestrand, F. Zong, J. Flygare, S.B. Wennerholm, and et al. Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features Oncoscience 1 8 2014 550 557
203. T.M. Westlake, A.C. Howlett, T.I. Bonner, L.A. Matsuda, and M. Herkenham Cannabinoid receptor binding and messenger RNA expression in Human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer brains Neuroscience 63 3 1994 637 652
204. A.C. White, J.A. Munson, A.E. Munson, and R.A. Carchman Effects of delta9-tetrahydrocannabinol in lewis lung adenocarcinoma cells in tissue culture J. Natl. Cancer Inst. 56 3 1976 655 658
205. J. Wijnholds, G. Scheffer, M. Van der Valk, P. Van der Valk, J. Beijnen, R. Scheper, and et al. Multidrug resistance protein 1 protects the oropharyngeal mucosal layer and the testicular tubules against drug-induced damage J. Exp. Med. 188 1998 797 808
206. J. Wijnholds, E. DeLange, G. Scheffer, D. Van den Berg, C. Mol, M. Van der Valk, and et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier J. Clin. Invest. 105 3 2000 279 285
207. T.M. Williams, F. Medina, I. Badano, R.B. Hazan, J. Hutchinson, W.J. Muller, and et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion J. Biol. Chem. 279 49 2004 51630 51646
208. K. Wright, N. Rooney, M. Feeney, J. Tate, D. Robertson, M. Welham, and et al. Differential expression of cannabinoid receptors in the Human colon: cannabinoids promote epithelial wound healing Gastroenterology 129 2 2005 437 453
209. X. Xu, Y. Liu, S. Huang, G. Liu, C. Xie, J. Zhou, and et al. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma Cancer Genet. Cytogenet. 171 1 2006 31 38
210. L. Zhang, and G. Barritt Evidence that TRPM8 is an androgen-dependent Ca2+channel required for the survival of prostate Cancer cells Cancer Res. 64 22 2004 8365 8373
211. L.X. Zhu, S. Sharma, M. Stolina, B. Gardner, M.D. Roth, D.P. Tashkin, and et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway J. Immunol. 165 1 2000 373 380
212. F. Ziglioli, A. Frattini, U. Maestroni, F. Dinale, M. Ciufifeda, and P. Cortellini Vanilloid-mediated apoptosis in prostate Cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism Acta Biomed. 80 1 2009 13 20